Table 3.

Adherence to CRC QCIs by Surgery/Pathology, Medical Oncology, and Radiation Oncology in 2006

Indicator No.*	QCI†	Eligible Patients	Adherence (%)		P‡
			Rate	Range
Surgery/pathology
1	CRC detection by screening	507	14	0-25	< .01
2	Documentation of staging	507	93	77-100	< .01
3	Barium enema or colonoscopy within 6 months	414	87	63-100	< .01
4	Copy of pathology report in record	321	98	93-100	.54
5	Depth of invasion (T level)	316	96	86-100	.32
6	LVI	316	76	53-100	< .01
7	PNI	316	39	5-83	< .01
8	Tumor differentiation (grade)	316	93	72-100	< .01
9	Radial margin for rectal cancer	64	42	0-100	.21
10	Distal and proximal margin status	316	97	86-100	.02
11	Removal of LNs	316	97	82-100	.01
12	Examination of LNs	305	100	100-100
13	No. of LNs examined	305	100	100-100
14	≥ 12 LNs examined for nonmetastatic colon cancer	250	72	53-88	.26
15	Involvement of LNs (N level)	305	100	100-100
17	Serum CEA before treatment for nonmetastatic CRC	321	78	47-100	< .01
18	Serum CEA post-treatment for nonmetastatic CRC	321	82	50-95	< .06
Medical oncology
19	Consideration of adjuvant chemotherapy (all stages)	436	95	77-100	< .01
20	Explanation for not considering for treatment (all stages)	23	96	50-100	.14
21	Consent for chemotherapy	321	69	38-100	< .01
22	Flow sheet for chemotherapy	321	86	63-100	< .01
23	Documented planned adjuvant chemotherapy dose	321	58	5-83	< .01
24	Compliance of planned dose with accepted regimens (nonmetastatic)	110	65	0-100	.33
25	Documentation of BSA	321	99	92-100	.27
26	Accepted regimen of adjuvant chemotherapy (nonmetastatic)	196	83	70-95	.50
27	Adjuvant chemotherapy within 8 weeks (nonmetastatic)	196	66	33-89	.02
28	Accepted regimen of neoadjuvant chemotherapy (nonmetastatic rectal cancer)	32	31	0-100	.07
29	Receipt of neoadjuvant chemotherapy within 8 weeks of diagnosis (nonmetastatic rectal cancer)	32	88	0-100	.02
Radiation oncology for rectal cancer
30	Consideration of radiation therapy	56	100	100-100
32	Consultation with radiation oncologist	56	93	67-100	.78
33	Accepted dosage of radiation treatment	52	71	38-100	.39
34	Receipt of neoadjuvant radiation treatment	52	73	0-100	.01
35	Receipt of adjuvant radiation treatment	52	29	0-100	.02

Abbreviations: BSA, body-surface area; CEA, carcinoembryonic antigen; CRC, colorectal cancer; LN, lymph node; LVI, lymphovascular invasion; PNI, perineural invasion; QCI, quality of care indicator.

^*Complete QCIs and indicator numbers can be found in Appendix Table A1 (online only). Indicator numbers included here for reference.

^†Indicators < 85% in bold font.

^‡P for variance across sites.